» Articles » PMID: 18385458

Distribution of Dipeptidyl Peptidase IV in Patients with Chronic Tonsillitis

Overview
Date 2008 Apr 4
PMID 18385458
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

In the pathogeneses of recurrent tonsillitis (RT) and tonsillar hypertrophy (TH), different immunological mechanisms are involved. Dipeptidyl peptidase IV (DPP IV) and aminopeptidase N (APN) participate in the regulation of the immune response during inflammation. In this study, the localization of DPP IV and the enzymatic activities of DPP IV and APN in 32 patients, 13 with RT and 19 with TH, who underwent tonsillectomy were investigated. The localization of DPP IV in tonsils was studied using histochemical and immunohistochemical methods. The enzymatic activities of DPP IV and APN in tonsillar lymphocytes and the patients' sera were determined kinetically at 37 degrees C using Gly-Pro-p-nitroanilide (for DPP IV) and Ala-p-nitroanilide (for APN) as chromogenic substrates. In samples from both RT and TH patients, DPP IV was found to localize mainly in extrafollicular areas of tonsillar tissue in a pattern corresponding to the T-cell distribution. Significantly higher (P < 0.001) levels of DPP IV and APN activities in sera from patients with TH than in sera from patients with RT were found. A correlation of DPP IV activities in sera and tonsillar lymphocytes from patients with TH was also found (r = 0.518; P < 0.05). Moreover, the results show that DPP IV and APN activities in sera decreased significantly with age. Tonsillar lymphocytes demonstrated a wide range of DPP IV and APN activities, without significant differences between the investigated groups. The results of this study show that the localization of DPP IV does not depend on the type of tonsillitis, whereas the variety in levels of DPP IV and APN activities in sera of patients with TH and RT suggests different patterns of participation of antigen-stimulated tonsils in the immune system.

Citing Articles

Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology.

Raha A, Chakraborty S, Henderson J, Mukaetova-Ladinska E, Zaman S, Trowsdale J Biosci Rep. 2020; 40(12).

PMID: 33205807 PMC: 7693198. DOI: 10.1042/BSR20203092.

References
1.
Fleischer B, Sturm E, De Vries J, Spits H . Triggering of cytotoxic T lymphocytes and NK cells via the Tp103 pathway is dependent on the expression of the T cell receptor/CD3 complex. J Immunol. 1988; 141(4):1103-7. View

2.
Gorrell M, Gysbers V, McCaughan G . CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand J Immunol. 2001; 54(3):249-64. DOI: 10.1046/j.1365-3083.2001.00984.x. View

3.
Sato Y, Fujiwara H, Higuchi T, Yoshioka S, Tatsumi K, Maeda M . Involvement of dipeptidyl peptidase IV in extravillous trophoblast invasion and differentiation. J Clin Endocrinol Metab. 2002; 87(9):4287-96. DOI: 10.1210/jc.2002-020038. View

4.
Lojda Z . Proteinases in pathology. Usefulness of histochemical methods. J Histochem Cytochem. 1981; 29(3A Suppl):481-93. DOI: 10.1177/29.3.481. View

5.
Durinx C, Neels H, Van der Auwera J, Naelaerts K, Scharpe S, De Meester I . Reference values for plasma dipeptidyl-peptidase IV activity and their association with other laboratory parameters. Clin Chem Lab Med. 2001; 39(2):155-9. DOI: 10.1515/CCLM.2001.026. View